AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 81 filers reported holding AUDENTES THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $1,751,000 | +3.6% | 44,228 | 0.0% | 0.21% | -2.8% |
Q2 2018 | $1,690,000 | -2.5% | 44,228 | -23.3% | 0.21% | -7.0% |
Q1 2018 | $1,733,000 | -20.4% | 57,677 | -17.2% | 0.23% | -20.6% |
Q4 2017 | $2,177,000 | +344.3% | 69,665 | +298.5% | 0.29% | +328.4% |
Q3 2017 | $490,000 | – | 17,481 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 1,806,832 | $50,862,321,000 | 38.71% |
Casdin Capital, LLC | 400,000 | $11,204,000 | 3.16% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,525,410 | $42,727,000 | 1.92% |
Opaleye Management Inc. | 180,000 | $5,041,000 | 1.78% |
Redmile Group, LLC | 1,289,332 | $36,114,000 | 1.78% |
Cormorant Asset Management, LP | 323,545 | $9,062,000 | 1.60% |
Orbimed Advisors | 4,129,638 | $115,671,000 | 1.10% |
Perceptive Advisors | 1,562,618 | $43,770,000 | 0.84% |
Rock Springs Capital Management LP | 525,000 | $14,705,000 | 0.68% |
SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,661,000 | 0.38% |